AXON NEUROSCIENCE SE
- Country
- 🇨🇾Cyprus
- Ownership
- Subsidiary
- Established
- 1999-04-06
- Employees
- 101
- Market Cap
- -
A 24-month Phase 1 Pilot Study of AADvac1 in Patients With Non Fluent Primary Progressive Aphasia
- Conditions
- Primary Progressive Nonfluent Aphasia
- Interventions
- Drug: AADvac1 40 µgDrug: AADvac1 160 µg
- First Posted Date
- 2017-06-05
- Last Posted Date
- 2019-11-14
- Lead Sponsor
- Axon Neuroscience SE
- Target Recruit Count
- 33
- Registration Number
- NCT03174886
- Locations
- 🇩🇪
Universitätsmedizin Göttingen, Klinik für Psychiatrie und Psychotherapie, Göttingen, Germany
🇩🇪Klinikum Rechts der Isar der TU München, Klinik und Poliklinik für Psychiatrie und Psychotherapie, München, Germany
🇩🇪Universitätsklinikum Ulm, Ulm, Germany
24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease
- Conditions
- Alzheimer's Disease
- Interventions
- Biological: AADvac1Drug: Placebo
- First Posted Date
- 2015-10-19
- Last Posted Date
- 2019-11-14
- Lead Sponsor
- Axon Neuroscience SE
- Target Recruit Count
- 208
- Registration Number
- NCT02579252
- Locations
- 🇦🇹
Universitätsklinik für Neurologie, Graz, Steiermark, Austria
🇦🇹Abteilung Psychiatrie und Psychotherapie, LKH Hall, Hall in Tirol, Tirol, Austria
🇩🇪Arzneimittelforschung Leipzig (AFL), Leipzig, Sachsen, Germany
18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease
- First Posted Date
- 2014-01-09
- Last Posted Date
- 2017-03-17
- Lead Sponsor
- Axon Neuroscience SE
- Target Recruit Count
- 25
- Registration Number
- NCT02031198
- Locations
- 🇦🇹
Univeristätsklinik für Neurologie, PMU, Christian-Doppler Klinik, Salzburg, Austria
🇦🇹Medizinische Universitat Graz, Graz, Steiermark, Austria
🇦🇹Medizinische Universitat Wien, Wien, Austria
Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease
- Conditions
- Alzheimer Disease
- Interventions
- Other: PlaceboBiological: AADvac1
- First Posted Date
- 2013-05-09
- Last Posted Date
- 2015-10-12
- Lead Sponsor
- Axon Neuroscience SE
- Target Recruit Count
- 30
- Registration Number
- NCT01850238
- Locations
- 🇦🇹
Univeristätsklinik für Neurologie, PMU, Christian-Doppler Klinik, Salzburg, Austria
🇦🇹Medizinische Universitat Wien, Wien, Austria
🇦🇹Medizinische Universitat Graz, Graz, Steiermark, Austria